ABBV
<% (signals.list.current.rate).substr(0,7) %>
<% signal.analyst %>
Last Updated: Jun 17, 2026 03:17:29 PM (GMT)
ABBV: The current live price is 222.01, with a percentage change from the previous price of -0.21%.
Support and Resistance Levels The current support levels are 222.47, 222.47, and 222.47. The resistance levels are 222.47, 222.47, and 222.47. The pivot point is also 222.47.
Indicators RSI is currently at 52.17, with a historical trend that has recently stabilized around this level. ATR is at 0.25959, indicating moderate volatility. The Parabolic SAR is positioned at 222.65357, suggesting a bearish momentum as the market price is below it. The MACD shows a positive histogram at 0.03495, indicating potential bullish momentum.
Market Sentiment The market price is below the pivot point (222.47), suggesting a bearish scenario supported by the SAR indicator.
ABBV Signals & Technical Analysis
Market Sentiment
Trend Indicators
Oscillators
Moving Averages
Pivot
About (abbv) AbbVie Inc.
Company Background
AbbVie Inc. (NYSE: ABBV) is a global biopharmaceutical company founded in 2013 as a spin-off from Abbott Laboratories. Headquartered in North Chicago, Illinois, AbbVie is dedicated to innovative research and development that leads to high-quality, effective therapies. The company's product portfolio primarily focuses on immunology, oncology, neuroscience, and virology, with a commitment to addressing complex health challenges. AbbVie has demonstrated consistent growth through strategic acquisitions and investments in cutting-edge research, enhancing its ability to deliver breakthrough therapies to patients worldwide.
Market Position
AbbVie holds a prominent position in the pharmaceutical industry, with a robust lineup of blockbuster drugs, including Humira, which has been one of the top-selling medications globally. Despite the impending patent expiration of Humira, AbbVie has strategically positioned itself to transition to newer products such as Rinvoq and Skyrizi, which are expected to capture significant market share in the immunology sector. The company's focus on research and development is evident in its pipeline, featuring numerous investigational therapies that promise to expand its market offerings and address unmet medical needs.
Key Financial Highlights
AbbVie has consistently delivered strong financial performance, with revenues in the billions driven by its diverse product portfolio. In the latest fiscal year, AbbVie reported revenues exceeding $58 billion, showcasing year-over-year growth. The company's strong cash flow generation supports both reinvestment in research and development and shareholder returns through dividends and stock repurchases. AbbVie has a robust commitment to returning value to its shareholders, highlighted by an attractive dividend yield, making it an appealing option for income-focused investors. Additionally, AbbVie's strategic collaborations and effective management of its assets enhance its resilience against market fluctuations and competitive pressures.
Industry Highlights
As a leader in the biopharmaceutical sector, AbbVie is at the forefront of addressing critical health challenges through groundbreaking innovation. The increasing demand for personalized medicine and biologics positions AbbVie to adapt and thrive in a rapidly evolving healthcare landscape. With a strong emphasis on patient-centric solutions and a commitment to advancing therapeutic options, AbbVie remains well-positioned for continued growth and success in the global market.
How to Buy or Trade AbbVie Inc. Stock (ABBV) with AvaTrade
Trading or investing in AbbVie Inc. stock through AvaTrade starts with opening a verified trading account. After registration, complete the KYC verification process by submitting your ID and proof of address, then fund your account using a supported payment method such as bank transfer, debit card, or e-wallet. Once your funds reflect, log into the AvaTrade platform or mobile app and search for the ticker symbol ABBV, which represents AbbVie Inc.. Before placing a trade, review the live AbbVie Inc. share price, market trend, spread, leverage options, and recent market news that could impact the stock price.
The next step is deciding whether you want to buy or sell AbbVie Inc. stock. Traders expecting the price to rise typically open a Buy position, while traders expecting weakness in the sector may open a Sell position using CFDs. Enter your preferred trade size, then apply risk management tools such as a stop-loss to limit downside exposure and a take-profit order to secure profits automatically. After confirming the trade, monitor key drivers including AbbVie Inc. earnings reports, product or service announcements, business segment performance, revenue growth, and overall stock market sentiment. Many traders also use technical indicators such as moving averages, RSI, and support/resistance levels available on the AvaTrade platform to improve timing and trading decisions.
Related Stocks
Sidebar rates
- <% signal.pair %>
<% signals.active.Current.rate.substr(0,7) %>
